Login / Signup

Leukocyte chemotactic factor 2-related amyloidosis presenting with severe jaundice and hepatic encephalopathy.

Hussam AlmasriAlmurtada RazokAhmed BadiMuneera AlmohannadiAbdo LutfMahir PetkarAbdel-Nasser Elzouki
Published in: Clinical case reports (2021)
Amyloidosis is a well-known disease with various types and subtypes. One of the most recently identified types is leukocyte chemotactic factor 2 amyloidosis (LECT 2), which was found to be common in certain ethnic backgrounds. It is suggested that the diagnosis of this type is vital to prevent any therapy-related complications when it is erroneously diagnosed as AL amyloidosis. The clinical presentation is usually slowly progressive kidney disease and mild hepatic impairment. We report a case of LECT2 amyloidosis, which presented with severe painless cholestasis and hepatic encephalopathy alongside progressive kidney disease.
Keyphrases
  • early onset
  • multiple myeloma
  • multiple sclerosis
  • drug induced
  • stem cells
  • risk factors
  • peripheral blood
  • bone marrow